{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:40:45Z","timestamp":1783478445400,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health New Technology Product Research and Development Project of Zhejiang Province","award":["2021PY030"],"award-info":[{"award-number":["2021PY030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82987-3","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:52:35Z","timestamp":1738309955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic association between immune-mediated inflammatory diseases and peripheral artery disease: a Mendelian randomization study"],"prefix":"10.1038","volume":"15","author":[{"given":"Haichao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"22","key":"82987_CR1","first-page":"1835","volume":"107","author":"B Tran","year":"2021","unstructured":"Tran, B. Assessment and management of peripheral arterial disease: what every cardiologist should know. Heart (British Cardiac Society). 107 (22), 1835\u20131843 (2021).","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"82987_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejvs.2018.03.004","volume":"55","author":"A Halliday","year":"2018","unstructured":"Halliday, A. & Bax, J. J. The 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS). Eur. J. Vascular Endovascular Surgery: Official J. Eur. Soc. Vascular Surg. 55 (3), 301\u2013302 (2018).","journal-title":"Eur. J. Vascular Endovascular Surgery: Official J. Eur. Soc. Vascular Surg."},{"issue":"3","key":"82987_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jvs.2021.01.066","volume":"74","author":"F Heidemann","year":"2021","unstructured":"Heidemann, F. et al. A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease. J. Vasc. Surg. 74 (3), 780\u2013787e787 (2021).","journal-title":"J. Vasc. Surg."},{"issue":"8","key":"82987_CR4","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song, P. et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Global Health. 7 (8), e1020\u2013e1030 (2019).","journal-title":"Lancet Global Health"},{"issue":"10","key":"82987_CR5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","volume":"132","author":"U Campia","year":"2019","unstructured":"Campia, U., Gerhard-Herman, M., Piazza, G. & Goldhaber, S. Z. Peripheral artery disease: past, Present, and future. Am. J. Med. 132 (10), 1133\u20131141 (2019).","journal-title":"Am. J. Med."},{"key":"82987_CR6","doi-asserted-by":"crossref","unstructured":"Pohlman, F. W. et al. Impact of risk factor control on peripheral artery disease outcomes and health disparities . (2022). Vascular medicine (London, England), 27(4): 323\u2013332 .","DOI":"10.1177\/1358863X221084360"},{"issue":"1","key":"82987_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2015.06.054","volume":"242","author":"F Ag\u00fcero","year":"2015","unstructured":"Ag\u00fcero, F. et al. Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders.Atherosclerosis 242 (1), 1\u20137 (2015).","journal-title":"Atherosclerosis"},{"issue":"10","key":"82987_CR8","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","volume":"21","author":"IB Mcinnes","year":"2021","unstructured":"Mcinnes, I. B. & Gravallese, E. M. Immune-mediated inflammatory disease therapeutics: past, present and future. Nat. Rev. Immunol. 21 (10), 680\u2013686 (2021).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"82987_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1160\/th15-07-0600","volume":"115","author":"YW Chuang","year":"2016","unstructured":"Chuang, Y. W. et al. Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study. Thromb. Haemost. 115 (2), 439\u2013445 (2016).","journal-title":"Thromb. Haemost."},{"issue":"52","key":"82987_CR10","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1097\/MD.0000000000002381","volume":"94","author":"TY Lin","year":"2015","unstructured":"Lin, T. Y., Chen, Y. G., Lin, C. L., Huang, W. S. & Kao, C. H. Inflammatory bowel disease increases the risk of peripheral arterial disease: a nationwide Cohort study. Medicine 94 (52), e2381 (2015).","journal-title":"Medicine"},{"issue":"3","key":"82987_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1756-185x.12025","volume":"16","author":"AA Hassan","year":"2013","unstructured":"Hassan, A. A., Habib, H. M. & Eissa, A. A. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study. Int. J. Rheum. Dis. 16 (3), 319\u2013324 (2013).","journal-title":"Int. J. Rheum. Dis."},{"issue":"11","key":"82987_CR12","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/rheumatology\/keaa414","volume":"59","author":"F Forte","year":"2020","unstructured":"Forte, F. et al. Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies. Rheumatol. (Oxford England). 59 (11), 3181\u20133192 (2020).","journal-title":"Rheumatol. (Oxford England)"},{"issue":"1","key":"82987_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/rheumatology\/key286","volume":"58","author":"R Charlton","year":"2019","unstructured":"Charlton, R. et al. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study. Rheumatol. (Oxford England). 58 (1), 144\u2013148 (2019).","journal-title":"Rheumatol. (Oxford England)"},{"issue":"R2","key":"82987_CR14","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani, G., Bowden, J. & Davey Smith, G. Evaluating the potential role of pleiotropy in mendelian randomization studies. Hum. Mol. Genet. 27 (R2), R195\u2013r208 (2018).","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"82987_CR15","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. Jama 326 (16), 1614\u20131621 (2021).","journal-title":"Jama"},{"issue":"24","key":"82987_CR16","doi-asserted-by":"publisher","first-page":"e017740","DOI":"10.1161\/JAHA.120.017740","volume":"9","author":"O Dikilitas","year":"2020","unstructured":"Dikilitas, O., Satterfield, B. A. & Kullo, I. J. Risk factors for Polyvascular involvement in patients with peripheral artery disease: a mendelian randomization study. J. Am. Heart Association. 9 (24), e017740 (2020).","journal-title":"J. Am. Heart Association"},{"issue":"16","key":"82987_CR17","doi-asserted-by":"publisher","first-page":"e025644","DOI":"10.1161\/JAHA.122.025644","volume":"11","author":"AG Hoek","year":"2022","unstructured":"Hoek, A. G., Van Oort, S., Elders, P. J. M. & Beulens, J. W. J. Causal association of cardiovascular risk factors and lifestyle behaviors with peripheral artery disease: a mendelian randomization approach. J. Am. Heart Association. 11 (16), e025644 (2022).","journal-title":"J. Am. Heart Association"},{"issue":"5","key":"82987_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/CIRCULATIONAHA.121.053797","volume":"144","author":"MG Levin","year":"2021","unstructured":"Levin, M. G. et al. Prioritizing the role of Major Lipoproteins and subfractions as risk factors for peripheral artery disease. Circulation 144 (5), 353\u2013364 (2021).","journal-title":"Circulation"},{"key":"82987_CR19","doi-asserted-by":"crossref","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical Res. ed), 362k601. (2018).","DOI":"10.1136\/bmj.k601"},{"issue":"2","key":"82987_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ng.3760","volume":"49","author":"KM De Lange","year":"2017","unstructured":"De Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49 (2), 256\u2013261 (2017).","journal-title":"Nat. Genet."},{"key":"82987_CR21","unstructured":"Andlauer, T. F. et al. M\u00fcller-Myhsok B. (2016). Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Science advances, 2(6): e1501678 ."},{"issue":"10","key":"82987_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53 (10), 1415\u20131424 (2021).","journal-title":"Nat. Genet."},{"key":"82987_CR23","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife, 7 (2018).","DOI":"10.7554\/eLife.34408"},{"issue":"5","key":"82987_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat. Genet. 50 (5), 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"82987_CR25","doi-asserted-by":"crossref","unstructured":"Weng, H. et al. Association between uric acid and risk of venous thromboembolism in East Asian populations: a cohort and Mendelian randomization study. The Lancet regional health Western Pacific, 39(100848. (2023).","DOI":"10.1016\/j.lanwpc.2023.100848"},{"key":"82987_CR26","doi-asserted-by":"crossref","unstructured":"Burgess, S., Bowden, J., Fall, T., Ingelsson, E. & Thompson, S. G. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology (Cambridge, Mass), 28(1): 30\u201342. (2017).","DOI":"10.1097\/EDE.0000000000000559"},{"issue":"6","key":"82987_CR27","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/ije\/dyx191","volume":"46","author":"E Slob","year":"2017","unstructured":"Slob, E., a W, Groenen, P. J. F., Thurik, A. R. & Rietveld, C. A. A note on the use of Egger regression in mendelian randomization studies. Int. J. Epidemiol. 46 (6), 2094\u20132097 (2017).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"82987_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet. Epidemiol. 40 (4), 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"issue":"3","key":"82987_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/ije\/dyaa216","volume":"50","author":"V Zuber","year":"2021","unstructured":"Zuber, V. et al. High-throughput multivariable mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease. Int. J. Epidemiol. 50 (3), 893\u2013901 (2021).","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"82987_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/ard.2003.018671","volume":"64","author":"I Del Rinc\u00f3n","year":"2005","unstructured":"Del Rinc\u00f3n, I., Haas, R. W., Pogosian, S. & Escalante, A. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann. Rheum. Dis. 64 (3), 425\u2013432 (2005).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"82987_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2010.05.007","volume":"212","author":"KS Stamatelopoulos","year":"2010","unstructured":"Stamatelopoulos, K. S. et al. Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis 212 (1), 305\u2013309 (2010).","journal-title":"Atherosclerosis"},{"key":"82987_CR32","unstructured":"Crowson, C. S. et al. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis7748\u201354 (Annals of the rheumatic diseases, 2018). 1."},{"issue":"10","key":"82987_CR33","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00296-019-04405-6","volume":"39","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Stiffening of aorta is more preferentially associated with rheumatoid arthritis than peripheral arteries. Rheumatol. Int. 39 (10), 1711\u20131721 (2019).","journal-title":"Rheumatol. Int."},{"issue":"2","key":"82987_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00296-022-05245-7","volume":"43","author":"T Zoubi","year":"2023","unstructured":"Zoubi, T. & Gordon, H. Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity. Rheumatol. Int. 43 (2), 221\u2013232 (2023).","journal-title":"Rheumatol. Int."},{"key":"82987_CR35","doi-asserted-by":"crossref","unstructured":"Birney, E. Mendelian randomization. Cold Spring Harbor Perspect. Med. 12 (4). J (2022).","DOI":"10.1101\/cshperspect.a041302"},{"issue":"4","key":"82987_CR36","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus, F. A., Piga, M., Azzolin, I., Mcconnell, R. & Iagnocco, A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun. rev. 20 (4), 102776 (2021).","journal-title":"Autoimmun. rev."},{"issue":"11","key":"82987_CR37","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2174\/138161212799504795","volume":"18","author":"WM Mellana","year":"2012","unstructured":"Mellana, W. M., Aronow, W. S., Palaniswamy, C. & Khera, S. Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy. Curr. Pharm. Design. 18 (11), 1450\u20131456 (2012).","journal-title":"Curr. Pharm. Design"},{"issue":"3","key":"82987_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3899\/jrheum.131037","volume":"41","author":"PH Dessein","year":"2014","unstructured":"Dessein, P. H. et al. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. J. Rhuematol. 41 (3), 429\u2013436 (2014).","journal-title":"J. Rhuematol."},{"issue":"1","key":"82987_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3899\/jrheum.140690","volume":"42","author":"R L\u00f3pez-Mejias","year":"2015","unstructured":"L\u00f3pez-Mejias, R. et al. Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis. J. Rhuematol. 42 (1), 39\u201345 (2015).","journal-title":"J. Rhuematol."},{"issue":"8","key":"82987_CR40","first-page":"e9782","volume":"12","author":"S Sedrakyan","year":"2020","unstructured":"Sedrakyan, S. et al. Evaluation of the risk of getting peripheral artery Disease in rheumatoid arthritis and the selection of appropriate diagnostic methods. Cureus 12 (8), e9782 (2020).","journal-title":"Cureus"},{"issue":"5","key":"82987_CR41","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cjca.2016.02.070","volume":"32","author":"A Harvey","year":"2016","unstructured":"Harvey, A., Montezano, A. C., Lopes, R. A., Rios, F. & Touyz, R. M. Vascular fibrosis in aging and hypertension: Molecular mechanisms and clinical implications. Can. J. Cardiol. 32 (5), 659\u2013668 (2016).","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"82987_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/clc.23105","volume":"42","author":"P Anyfanti","year":"2019","unstructured":"Anyfanti, P. et al. Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis. Clin. Cardiol. 42 (1), 62\u201368 (2019).","journal-title":"Clin. Cardiol."},{"key":"82987_CR43","doi-asserted-by":"crossref","unstructured":"Bassu, S. et al. Oxidative stress biomarkers and peripheral endothelial dysfunction in rheumatoid arthritis: a monocentric cross-sectional case-control study. Molecules (Basel Switzerland), 25(17): (2020).","DOI":"10.3390\/molecules25173855"},{"key":"82987_CR44","doi-asserted-by":"crossref","unstructured":"England, B. R., Thiele, G. M., Anderson, D. R. & Mikuls, T. R. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. (2018). BMJ (Clinical research ed), 361k1036 .","DOI":"10.1136\/bmj.k1036"},{"issue":"null","key":"82987_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.phrs.2017.12.025","volume":"130","author":"T Hu\u0107","year":"2018","unstructured":"Hu\u0107, T., Nowinski, A., Drapala, A., Konopelski, P. & Ufnal, M. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats. Pharmacol. Res. 130 (null), 172\u2013179 (2018).","journal-title":"Pharmacol. Res."},{"issue":"7351","key":"82987_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474 (7351), 298\u2013306 (2011).","journal-title":"Nature"},{"issue":"null","key":"82987_CR47","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England, B. R., Thiele, G. M., Anderson, D. R. & Mikuls, T. R. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ (Clinical Res. ed). 361 (null), k1036 (2018).","journal-title":"BMJ (Clinical Res. ed)"},{"key":"82987_CR48","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.avsg.2021.07.010","volume":"78","author":"J Golledge","year":"2022","unstructured":"Golledge, J., Velu, R., Quigley, F., Jenkins, J. & Singh, T. P. Cohort study examining the association of immunosuppressant drug prescription with major adverse cardiovascular and limb events in patients with peripheral artery disease. Ann. Vasc. Surg. 78, 310\u2013320 (2022).","journal-title":"Ann. Vasc. Surg."},{"issue":"12","key":"82987_CR49","doi-asserted-by":"publisher","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","volume":"17","author":"M Pujades-Rodriguez","year":"2020","unstructured":"Pujades-Rodriguez, M., Morgan, A. W., Cubbon, R. M. & Wu, J. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med. 17 (12), e1003432 (2020).","journal-title":"PLoS Med."},{"issue":"5","key":"82987_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/annrheumdis-2020-219065","volume":"80","author":"E Ha","year":"2021","unstructured":"Ha, E., Bae, S. C. & Kim, K. Large-scale meta-analysis across east Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann. Rheum. Dis. 80 (5), 558\u2013565 (2021).","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"82987_CR51","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47 (12), 1457\u20131464 (2015).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82987-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:54:45Z","timestamp":1738310085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82987-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["82987"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82987-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3473912\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3891"}}